EDEN PRAIRIE, Minn., Aug. 16, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that John Erb, CEO, will be a featured presenter at the 6th Annual Intellisight Conference on Tuesday, August 22, 2017 from 3:35pm – 4:10pm central time in Minneapolis. Interested parties can view the Company’s live presentation via the website http://wsw.com/webcast/intel17/chfs and the webcast replay will remain accessible via the conference event page at: www.gointellisight.org.
The two-day Intellisight investor conference, hosted by the CFA Society of Minnesota, will take place this year on Tuesday and Wednesday, August 22 and 23, 2017 at University of St. Thomas’ Minneapolis Campus in the Schulze School of Entrepreneurship located in downtown Minneapolis. For further details, including registration information, please visit www.gointellisight.org or call the CFA Society at 612-317-2889.
About CHF Solutions
CHF Solutions, Inc. (NASDAQ:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis® therapy. The Aquadex FlexFlow system, is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's objective is to improve the quality of life for patients with heart failure and related conditions. CHF Solutions is a Delaware corporation headquartered in Minneapolis with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ Capital Market since February 2012.